| Followers | 905 |
| Posts | 39660 |
| Boards Moderated | 7 |
| Alias Born | 03/22/2016 |
Wednesday, September 04, 2024 6:26:27 AM
that was top, early bird gets the worm
Recent CMMB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:15:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/23/2026 08:07:51 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/20/2026 08:05:20 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/19/2026 12:05:05 PM
- Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/17/2026 01:00:00 PM
- Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit • GlobeNewswire Inc. • 11/24/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/21/2025 11:15:37 AM
- Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/20/2025 01:00:00 PM
- Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 11/06/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2025 08:05:14 PM
- Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 08/21/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2025 12:01:04 PM
- Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2025 08:33:11 PM
